हाल में देखा गया

  • होम
  • स्टोरी
  • News Announcement
  • Thyrocare Technologies: Board Meeting Intimation for Consideration And Approval Of Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31 2025 And Recommendation Of The Final Dividend If Any For The Financial Year 2024-25.
News Announcement

Thyrocare Technologies: Board Meeting Intimation for Consideration And Approval Of Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31 2025 And Recommendation Of The Final Dividend If Any For The Financial Year 2024-25.

15-अप्रैल-2025 Follow Value Research Online on Google download pdfडाउनलोड पीडीएफ़ Thyrocare Tech

Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/04/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2025 and to recommend the final dividend if any for the financial year 2024-25.

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.